Baker Bros. Advisors as of March 31, 2011
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 51 positions in its portfolio as reported in the March 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Genomic Health | 13.3 | $84M | 7.5M | 11.21 | |
| Ardea Biosciences | 11.5 | $73M | 6.0M | 12.06 | |
| InterMune | 11.1 | $70M | 1.5M | 47.19 | |
| Auxilium | 9.0 | $57M | 7.3M | 7.76 | |
| Alere | 7.2 | $46M | 1.2M | 39.14 | |
| Pharmasset | 6.0 | $38M | 1.8M | 21.62 | |
| Halozyme Therapeutics (HALO) | 4.2 | $27M | 3.9M | 6.71 | |
| Ym Biosciences | 3.8 | $24M | 9.1M | 2.64 | |
| BioCryst Pharmaceuticals (BCRX) | 3.3 | $21M | 5.6M | 3.79 | |
| Pharmacyclics | 2.0 | $13M | 2.2M | 5.89 | |
| Exelixis (EXEL) | 1.9 | $12M | 1.1M | 11.33 | |
| Medivation | 1.7 | $11M | 583k | 18.64 | |
| Micromet | 1.7 | $11M | 1.9M | 5.60 | |
| BioMarin Pharmaceutical (BMRN) | 1.6 | $9.8M | 388k | 25.13 | |
| Adolor Corporation (ADLR) | 1.5 | $9.7M | 6.9M | 1.40 | |
| Biomarin Pharmaceutical Inc note 1.875% 4/2 | 1.4 | $8.7M | 6.4M | 1.36 | |
| Trimeris | 1.4 | $8.7M | 3.5M | 2.51 | |
| BioDelivery Sciences International | 1.3 | $8.5M | 2.4M | 3.53 | |
| Amicus Therapeutics (FOLD) | 1.3 | $8.0M | 1.1M | 7.09 | |
| Human Genome cv 2.25% | 1.1 | $7.2M | 4.5M | 1.60 | |
| Anacor Pharmaceuticals | 1.1 | $7.2M | 1.0M | 6.92 | |
| ACADIA Pharmaceuticals (ACAD) | 1.1 | $7.1M | 4.4M | 1.62 | |
| Alere Inc note 3.000% 5/1 | 1.1 | $6.8M | 6.0M | 1.13 | |
| Alkermes | 1.0 | $6.5M | 505k | 12.95 | |
| Dendreon Corp note | 1.0 | $6.4M | 6.0M | 1.06 | |
| Achillion Pharmaceuticals | 0.9 | $5.7M | 802k | 7.15 | |
| Threshold Pharma | 0.9 | $5.7M | 3.7M | 1.54 | |
| ZIOPHARM Oncology | 0.9 | $5.6M | 890k | 6.25 | |
| Anthera Pharmaceuticals | 0.9 | $5.4M | 800k | 6.75 | |
| GTx | 0.7 | $4.5M | 1.7M | 2.57 | |
| Chelsea Therapeutics International | 0.7 | $4.3M | 1.1M | 3.88 | |
| Inhibitex | 0.5 | $3.4M | 928k | 3.62 | |
| Salix Pharmaceuticals | 0.5 | $2.9M | 83k | 35.03 | |
| AVANIR Pharmaceuticals | 0.3 | $2.0M | 500k | 4.08 | |
| XenoPort | 0.3 | $1.9M | 313k | 5.93 | |
| DepoMed | 0.3 | $1.8M | 183k | 10.04 | |
| Alnylam Pharmaceuticals (ALNY) | 0.2 | $1.6M | 166k | 9.56 | |
| A.P. Pharma (APPA) | 0.2 | $1.6M | 6.9M | 0.23 | |
| Xoma | 0.2 | $1.1M | 400k | 2.79 | |
| Ligand Pharmaceuticals | 0.1 | $836k | 84k | 10.00 | |
| Idera Pharmaceuticals | 0.1 | $761k | 288k | 2.64 | |
| Infinity Pharmaceuticals (INFIQ) | 0.1 | $628k | 107k | 5.88 | |
| Pozen | 0.1 | $618k | 115k | 5.37 | |
| Cumberland Pharmaceuticals (CPIX) | 0.1 | $533k | 96k | 5.53 | |
| Cadence Pharmaceuticals | 0.1 | $355k | 39k | 9.17 | |
| Alere | 0.0 | $202k | 732.00 | 275.96 | |
| Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) | 0.0 | $96k | 22k | 4.29 | |
| Anadys Pharmaceuticals (ANDS) | 0.0 | $70k | 61k | 1.16 | |
| Amylin Pharmaceuticals Inc note 2.500% 4/1 | 0.0 | $3.0k | 3.0k | 1.00 | |
| Aradigm Corporation (ARDM) | 0.0 | $18k | 100k | 0.18 | |
| VIA Pharmaceuticals (VIAP) | 0.0 | $6.2k | 103k | 0.06 |
